MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

56.16 -0.09 (-0.16%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,033,021
Open 56.33
Bid (Size) 56.00 (100)
Ask (Size) 56.66 (500)
Prev. Close 56.25
Today's Range 55.77 - 56.53
52wk Range 42.52 - 62.89
Shares Outstanding 2,222,113,553
Dividend Yield 4.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol-Myers Squibb’s Q1 Earnings Call: Our Top 5 Analyst Questions
Bristol-Myers Squibb’s first quarter results were notably shaped by ongoing momentum in its growth portfolio and steady execution across key marketed product... 
Via StockStory
Topics Earnings

Performance

YTD
+5.1%
+5.1%
1 Month
-5.1%
-5.1%
3 Month
-9.4%
-9.4%
6 Month
+20.3%
+20.3%
1 Year
+19.8%
+19.8%

More News

Read More
News headline image
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb (NYSE:BMY) Q1 2026 Earnings Beat Driven by Growth Portfolio ↗
Via Chartmill
Topics Earnings
News headline image
1 Healthcare Stock with Competitive Advantages and 2 Facing Challenges
Via StockStory
News headline image
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™
From Bristol Myers Squibb
Via Business Wire
News headline image
BMY Q1 Deep Dive: Growth Portfolio, Pipeline Milestones, and Anticipated Late-Stage Readouts
Via StockStory
News headline image
Why Bristol Myers Squibb Stock Rocked the Market Today ↗
Via The Motley Fool
News headline image
Bristol Myers (BMY) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Bristol-Myers Squibb (NYSE:BMY) Exceeds Q1 CY2026 Expectations
Via StockStory
News headline image
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Earnings To Watch: Bristol-Myers Squibb (BMY) Reports Q1 Results Tomorrow
Via StockStory
News headline image
3 Healthcare Stocks That Pay You While You Wait for the Growth ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Biotech Stocks That Could Benefit from the Patent Cliff ↗
Via MarketBeat
Topics Intellectual Property
News headline image
Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Bristol Myers Squibb: Low Volatility Meets High Dividend Yield ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery ↗
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
1 Unpopular Stock That Should Get More Attention and 2 We Question
Via StockStory
News headline image
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗
Via The Motley Fool
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
Which Dividend Pharma Stock Should a Value Investor Choose Today? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Recession Resistant Dividend Stocks to Buy Now While They're Still Cheap ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Neurocrine Biosciences (NBIX): A New Era in Neuroscience and Endocrinology
Via Finterra
Topics Earnings Economy Intellectual Property

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 56.16
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 05/08/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 124.79B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 125B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story